Skip to main content
. 2021 Jan 19;325(3):254–264. doi: 10.1001/jama.2020.25864

Figure 2. Primary Outcome and Clinical Status at 30 Days.

Figure 2.

For the primary outcome, the mean number of days alive and out of the hospital was 21.9 days (SD, 8.0 days) in the discontinue use of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB) group vs 22.9 days (SD, 7.1 days) in the continue use of ACEI or ARB group (median, 25.0 days [interquartile range, 20.0-27.0 days] vs 25.0 days [interquartile range, 21.0-27.0 days], respectively) and the between-group mean ratio was 0.95 (95% CI, 0.90-1.01; P = .09).